Quadrant Capital Group LLC Outset Medical, Inc. Transaction History

Quadrant Capital Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$3.07 - $10.25 $282 - $943	92 New	92 $0
Q2 2023 Aug 09, 2023	SELL	$17.18 - $23.76 $103 - $142	-6 Reduced 1.48%	399 $8,000
Q1 2023 May 11, 2023	SELL	$18.25 - $30.26 $1,113 - $1,845	-61 Reduced 13.09%	405 $7,000
Q4 2022 Feb 10, 2023	BUY	$12.36 - $26.41 $3,250 - $6,945	263 Added 129.56%	466 $12,000
Q3 2022 Nov 10, 2022	BUY	$14.67 - $21.7 $440 - $651	30 Added 17.34%	203 $3,000

Q2 2022 Aug 09, 2022	BUY	$13.46 - $48.16 $2,328 - $8,331	173 New	173 $3,000
Q1 2022 May 06, 2022	SELL	$34.22 - $47.24 $273 - $377	-8 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$43.29 - $58.77 $173 - $235	-4 Reduced 33.33%	8 $0
Q3 2021 Nov 12, 2021	BUY	$36.86 - $54.98 $36 - $54	1 Added 9.09%	12 $1,000
Q2 2021 Aug 09, 2021	BUY	$41.49 - $59.92 $456 - $659	11 New	11 $1,000

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $184M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.